Literature DB >> 12372075

Sporotrichosis.

R Morris-Jones1.   

Abstract

Sporotrichosis is a cutaneous fungal infection with a global distribution. The disease has several clinical forms, primarily cutaneous with associated lymphadenopathy. However, dissemination to osteoarticular structures and viscera may occur, both in healthy and immunosuppressed individuals; such disseminated forms usually follow spread after inhalation of fungal spores. Cutaneous infection is usually associated with trauma during the course of outdoor work, and treatment is required for the majority of patients. Potassium iodide (the treatment of choice in endemic areas) is an effective and inexpensive therapy; however, its adverse effects and complicated dosage regimen often weigh against its use in developed countries, where itraconazole is the antimycotic of choice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372075     DOI: 10.1046/j.1365-2230.2002.01087.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  25 in total

1.  In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases.

Authors:  Luciana Trilles; Belkys Fernández-Torres; Márcia Dos Santos Lazéra; Bodo Wanke; Armando de Oliveira Schubach; Rodrigo de Almeida Paes; Isabel Inza; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

2.  Fixed sporotrichosis as a cause of a chronic ulcer on the knee.

Authors:  Rodrigo Roldán-Marín; José Contreras-Ruiz; Roberto Arenas; Elsa Vazquez-del-Mercado; Sonia Toussaint-Caire; María Elisa Vega-Memije
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

3.  Use of mycelial-phase Sporothrix schenckii exoantigens in an enzyme-linked immunosorbent assay for diagnosis of sporotrichosis by antibody detection.

Authors:  Rodrigo Almeida-Paes; Monique A Pimenta; Claudia Vera Pizzini; Paulo Cezar F Monteiro; José Mauro Peralta; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

4.  Phenotypic and molecular identification of Sporothrix isolates from an epidemic area of sporotrichosis in Brazil.

Authors:  Manoel Marques Evangelista Oliveira; Rodrigo Almeida-Paes; Mauro Medeiros Muniz; Maria Clara Gutierrez-Galhardo; Rosely Maria Zancope-Oliveira
Journal:  Mycopathologia       Date:  2011-06-24       Impact factor: 2.574

5.  Ribosomal DNA sequencing and phylogenetic analysis of environmental Sporothrix schenckii Strains: comparison with clinical isolates.

Authors:  Giuseppe Criseo; Orazio Romeo
Journal:  Mycopathologia       Date:  2010-02-02       Impact factor: 2.574

Review 6.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

7.  Characterization of virulence profile, protein secretion and immunogenicity of different Sporothrix schenckii sensu stricto isolates compared with S. globosa and S. brasiliensis species.

Authors:  Geisa Ferreira Fernandes; Priscila Oliveira dos Santos; Anderson Messias Rodrigues; Alexandre Augusto Sasaki; Eva Burger; Zoilo Pires de Camargo
Journal:  Virulence       Date:  2013-01-16       Impact factor: 5.882

8.  Disseminated cutaneous sporotrichosis associated with ocular lesion in an immunocompetent patient.

Authors:  Karina Bittencourt Medeiros; Luana Gomes Landeiro; Lucia Martins Diniz; Aloísio Falqueto
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

9.  Detrimental role of endogenous nitric oxide in host defence against Sporothrix schenckii.

Authors:  Karla Simone S Fernandes; Edward Helal Neto; Marcelly M S Brito; João S Silva; Fernando Q Cunha; Christina Barja-Fidalgo
Journal:  Immunology       Date:  2008-01-09       Impact factor: 7.397

Review 10.  Current research on the immune response to experimental sporotrichosis.

Authors:  Iracilda Zeppone Carlos; Micheli Fernanda Sassá; Diana Bridon da Graça Sgarbi; Marisa Campos Polesi Placeres; Danielle Cardoso Geraldo Maia
Journal:  Mycopathologia       Date:  2009-02-25       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.